Preventive Effect of Preoperative Intranasal Dexmedetomidine for Postoperative Delirium in Elderly Patients with Sleep Disorders Undergoing Major Noncardiac Surgery: A Randomized, Triple-Blind, Placebo-Controlled Trial

Dec 12, 2025Drug design, development and therapy

Intranasal Dexmedetomidine Before Surgery May Prevent Delirium After Major Non-Heart Surgery in Older Patients with Sleep Problems

AI simplified

Abstract

The incidence of (POD) was 18.4% in the group compared to 32.8% in the placebo group.

  • Preoperative intranasal dexmedetomidine is associated with a lower risk of POD in elderly patients with sleep disorders.
  • Patients receiving dexmedetomidine experienced improved sleep quality, including an increase in total sleep time and sleep efficiency.
  • No significant differences were observed in delayed neurocognitive recovery at 7 or 30 days postoperatively between the two groups.
  • Dexmedetomidine was linked to a higher incidence of bradycardia on the night before surgery compared to placebo.
  • The overall incidence of other adverse events was similar between the dexmedetomidine and placebo groups.

AI simplified

Key numbers

18.4% vs 32.8%
Decrease in Incidence
Incidence of within 5 days post-surgery.
6.2 hours vs 5.3 hours
Total Sleep Time Increase
Mean total sleep time on the night before surgery.
37.9% vs 16.7%
Bradycardia Incidence Increase
Incidence of bradycardia on the night before surgery.

Full Text

We can’t show the full text here under this license. Use the link below to read it at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free